Sorafenib
目录号: A17857
Raf/VEGFR3 抑制剂
Sorafenib(Bay 43-9006)是一种强效的口服多激酶抑制剂,其半抑制浓度(IC50)分别为6 nM、20 nM和22 nM,针对Raf-1、B-Raf和VEGFR-3。
全国免运费, 顺丰次日达
重要通知:仅供研究使用。我们不向患者销售。
Raf/VEGFR3 抑制剂
重要通知:仅供研究使用。我们不向患者销售。
Discription | Sorafenib (Bay 43-9006) is a potent, orally active multikinase inhibitor with IC50s of 6 nM, 20 nM, and 22 nM for Raf-1, B-Raf, and VEGFR-3, respectively. | |||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
目录号 | A17857 |
---|---|
分子式 | C21H16ClF3N4O3 |
分子量 | 464.83 |
CAS号 | 284461-73-0 |
SMILES | O=C(NC(C=C1)=CC=C1OC2=CC(C(NC)=O)=NC=C2)NC3=CC=C(Cl)C(C(F)(F)F)=C3 |
其他名称 | Bay 43-9006, Bay-43-9006, Bay43-9006 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | Warmed: 59 mg/mL (126.92 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 5%DMSO+45%PEG400+50%H2O | 0.35 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.51 mL | 107.57 mL | 215.13 mL |
0.5 mM | 4.3 mL | 21.51 mL | 43.03 mL |
1 mM | 2.15 mL | 10.76 mL | 21.51 mL |
5 mM | 0.43 mL | 2.15 mL | 4.3 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2